Altis Labs

About:

Altis helps biopharma run faster and more successful clinical trials using AI models trained on the world's largest cancer imaging database.

Website: https://altislabs.com/

Twitter/X: altislabs

Top Investors: Creative Destruction Lab (CDL), Benchstrength, Debiopharm Innovation Fund, Rich Gliklich, Douglas Foster

Description:

Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinical information, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.

Total Funding Amount:

7.9M CAD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2019-01-01

Contact Email:

info(AT)altislabs.com

Founders:

Felix Baldauf-Lenschen

Number of Employees:

11-50

Last Funding Date:

2023-06-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai